Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen
Latest Information Update: 03 May 2023
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Prasugrel (Primary) ; Sirolimus (Primary) ; Ticagrelor (Primary)
- Indications Coronary artery disease; Myocardial infarction; Stroke; Thrombosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms MASTER DAPT
- 06 Mar 2023 Results from substudy assessing whether Abbreviated DAPT therapy is noninferior to the standard DAPT therapy in NACE and MACCE regardless of regional variation , presented at the 72nd Annual Scientific Session of the American College of Cardiology together with the World Heart Federation
- 27 Sep 2022 Results assessing safety and efficacy of an abbreviated APT regimen after coronary stenting in a high bleeding risk population presenting with acute or recent myocardial infarction published in the Journal of the American College of Cardiology
- 23 Aug 2022 Results of an analysis assessed the impact of nonadherence to the medication published in the Journal of the American College of Cardiology